Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain

Pain

Volumn 83, Issue 3, 1999, Pages 433-440

  Christensen, Dennis ^a   Gautron, Michèle ^a   Guilbaud, Gisèle ^a   Kayser, Valérie ^a  

^a INSERM   (France)

Author keywords

Glycine NMDA receptor antagonist; Morphine attenuates; Trigeminal neuropathic pain disorders

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; GLYCINE RECEPTOR ANTAGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; INFRAORBITAL NERVE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; MOTOR COORDINATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINUS NEURALGIA;

ANALGESICS, OPIOID; ANIMALS; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MORPHINE; PAIN MEASUREMENT; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE; TRIGEMINAL NEURALGIA;

EID: 0032703851     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00126-8     Document Type: Article

References (61)

1. Advokat C., Rhein F.Q. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res. 699:1995;157-160.
2. Attal N., Chen Y.L., Kayser V., Guilbaud G. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy. Pain. 41:1991;235-251.
3. Basbaum A.I., Gautron M., Jazat F., Mayes M., Guilbaud G. The spectrum of fiber loss in a model of neuropathic pain in the rat: an electron microscopic study. Pain. 47:1991;359-367.
4. Bennett G.J., Xie Y.K. A peripheral monomeuropathy in rat that produces pain sensation like those seen in man. Pain. 33:1988;87-107.
5. Benoist J.-M., Gautron M., Guilbaud G. Alteration of neuronal activity in the cortical projection area of the pad vibrissae in rats with pain-related behaviours from the trigeminal area. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Proc 8th World Cong: Pain, Progress in Pain Research and Management. Vol 8. 1997;561-573 IASP Press, Seattle.
6. Benoist J.M., Gautron M., Guilbaud G. Experimental model of trigeminal pain in the rat by constriction of one infraorbital nerve (IoN): changes in neuronal activities in the Sm1 cortices corresponding to the IoN. Exp Brain Res. 126:1999;383-398.
7. Bereiter D.A., Bereiter D.F. N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor antagonism reduces Fos-like immunoreactivity in central trigeminal neurons after corneal stimulation in the rat. Neuroscience. 73:1996;249-258.
8. Besse D., Lombard M.C., Perrot S., Besson J.M. Regulation of opioid binding sites in the superficial dorsal horn of the rat spinal cord following loose ligation of the sciatic nerve: comparison with sciatic nerve section and lumbar dorsal rhizotomy. Neuroscience. 50:1992;921-933.
9. Burchiel K.J. Trigeminal neuropathic pain. Acta Neurochir. 58:1993;145-149.
10. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
11. Chapman V., Haley J.E., Dickenson A.H. Electrophysiological analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology. 81:1994;1429-1435.
12. Chapman V., Honoré P., Buritova J., Besson J.M. The contribution of NMDA receptor activation to spinal c-fos expression in a model of inflammatory pain. Brit J Pharmacol. 116:1995;1628-1634.
13. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a (MU)-opioid. Neuron. 7:1991;319-326.
14. Chiang C.Y., Hu J.W., Sessle B.J. NMDA receptor involvement in neuroplastic changes induced by neonatal capsaicin treatment in trigeminal nociceptive neurons. J Neurophysiol. 78:1997;2799-2803.
15. Christensen D., Idänpään-Heikkilä J.J., Guilbaud G., Kayser V. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist (+)-HA966 in a rat model of neuropathic pain. Brit J Pharmacol. 125:1998;1641-1650.
16. DeMulder P.A., Claus M., DeMulder G., Adriaensen H., Vos B.P. Effects of morphine and ketamine on behavioural signs of increased trigeminal nociceptive activity after chronic constriction injury to the rat's infraorbital nerve. Soc Neurosci Abstr. 20:1994;555.
17. Dickenson A.H. NMDA receptor antagonists: interactions with opioids. Acta Anaesthesiol Scand. 41:1997;112-115.
18. Dodd J., Kelly J.P. Trigeminal system. Kandel E.R., Schwarz J.H., Jessel T.M. Principles of neural science, vol. 3. 1991;701-710 Elsevier, New York.
19. Eisenberg E., Vos B.P., Strassman A.M. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain. 54:1993;301-307.
20. Fields H.L. Treatment of Trigeminal Neuralgia. N. Eng J Med. 334:1996;1125-1126.
21. Fromm GH, Sessle BJ. Trigeminal neuralgia: current concepts regarding pathogenesis and Treatment,Boston:Butterworth-Heinemann 1991. pp1-230.
22. Gautron M., Jazat F., Ratinahirana H., Hauw J.J., Guilbaud G. Alterations in myelinated fibres in the sciatic nerve of rats after constriction: possible relationships between the presence of abnormal small myelinated fibres and pain-related behaviour. Neurosci Lett. 111:1990;28-33.
23. Goff J.R., Burkey A.R., Goff D.J., Jasmin L. Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience. 82:1998;559-574.
24. Grass S., Hoffmann O., Wiessenfeld-Hallin Z. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol Scand. 158:1996;269-273.
25. Gregg J.M. A surgical approach to the ophtalmic-maxillary nerve trunks in the rat. J Dent Res. 52:1973;392.
26. Idänpään-Heikkilä J.J., Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain-baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain. 79:1999;281-290.
27. Idänpään-Heikkilä J.J., Perrot S., Guilbaud G., Kayser V. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK-B receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics. Eur J Pharmacol. 325:1997;155-164.
28. Imamura Y., Kawamoto H., Nakanishi O. Characterization of heat-hyperalgesia in an experimental trigeminal neuropathy in rats. Exp Brain Res. 116:1997;97-103.
29. Jadad A.R., Carroll D., Glynn C.J., Moore R.A., McQuay H.J. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet. 339:1992;1367-1371.
30. Jacquin M.F., Zeigler H.P. Trigeminal oroensation and ingestive behavior in the rat. Behav Neurosci. 97:1983;62-97.
31. Kangra I., Randic M. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- and high-threshold primary afferent fibres. Brain Res. 553:1991;347-352.
32. Kauppila T., Xiao-Jun X., Wei Y., Wiesenfeld-Hallin Z. Dextromethorphan potentiates the effect of morphine in rats with a peripheral neuropathy. NeuroReport. 9:1998;1071-1074.
33. Kayser V., Lee H., Guilbaud G. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy. Neuroscience. 64:1995;537-545.
34. Kemp J.A., Leeson P.D. The glycine site of the NMDA receptor-five years on. Trends Pharmacol. 14:1993;20-25.
35. Kryzhanovski G.N., Reshnyak V.K., Dolgikh V.G., Gorizontova M.P., Speranskaya T.V. Trigeminal neuralgia of neuropathic origin. Bull Exp Biol Med (Eng). 112:1992;1059-1062.
36. Kryzhanovski G.N., Dolgikh V.G., Gorizontova M.P., Mironova I.V. Formation of a pathological system in rats with neuropathic trigeminal neuralgia. Bull Exp Biol Med (Eng). 115:1993;623-625.
37. Le Bars D., Rivot J.P., Guilbaud G., Menetrey D., Besson J.M. The depressive effects of morphine on the C fibre response of dorsal horn neurones in the spinal rat pretreated or not by pCPA. Brain Res. 176:1979;337-353.
38. Loeser J.D. Tic douloureux and atypical face pain. Wall P.D., Melzack P. The textbook of pain. 3rd ed :1994;699-710 Churchill-Livingston, London.
39. Magnusson K.R., Larson A.A., Madl J.E., Altschuler R.A., Beitz A.J. Co-localization of fixative-modified glutamate and glutaminase in neurons of the spinal trigeminal nucleus of the rat: an immunohistochemical and immunoradiochemical analysis. J Comp Neurol. 247:1986;477-490.
40. Mauskop A. Trigeminal neuralgia (tic douloureux). J Pain Symptom Manage. 8:1993;148-154.
41. Millan M.J., Seguin L. Chemically-diverse ligands at the glycine B site coupled to N-methyl-D- aspartate (NMDA) receptors selectively block the late phase of formalin- induced pain in mice. Neurosci Lett. 178:1994;139-143.
42. Munger B.L., Bennett G.J., Kajander K.C. An experimental painful peripheral neuropathy due to nerve constriction. I. Axonal pathology in the sciatic nerve. Exp Neurol. 118:1992;204-214.
43. Munger B.L., Bennett G.B., Vos B.P. Abnormal sensory reinnervation of mystacial guard hairs in long term chronic constrictive injury (CCI) of the infraorbital nerve (ION) in rats. Soc Neurosci Abstr. 22:1996;1487.
44. Nichols M.L., Bian D., Ossipov M.H., Lai J., Porreca F. Regulation of opioid antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther. 275:1995;1339-1345.
45. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine to Dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain. 69:1997;317-322.
46. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett. 1995;87-90.
47. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
48. Salt T.E., Hill R.G. Pharmacological differentiation between responses of rat medullary dorsal horn neurons to noxious mechanical and noxious thermal cutaneous stimuli. Brain Res. 263:1983;167-171.
49. Stanfa L., Dickenson A., Xu X.J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia. Trends Pharm Sci. 15:1994;65-66.
50. Sweet W.H. Deafferentation pain after posterior rhizotomy, trauma to a limb, and herpes zoster. Neurosurgery. 15:1984;928-932.
51. Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol. 7:1984;51-82.
52. Taddese A., Nah S.Y., McCleskey E.W. Selective opioid inhibition of small nociceptive neurons. Science. 270:1995;1366-1369.
53. Tallaksen-Greene S.J., Young A.B., Penney J.B., Beitz A.J. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett. 141:1992;79-83.
54. Vos B.P., Maciewicz R.J. Alterations of peripheral nerve morphology and changes in fluorideresistant phophatase and substance P-immunoreactivity in the trigeminal nucleus caudalis in an experimental model of trigeminal neuropathic pain. Am Pain Soc Abstr. 9:1990;56.
55. Vos B.P., Strassman A.M. Fos expression in the medullary dorsal horn of the rat after chronic constriction injury to the infraorbital nerve. J Comp Neurol. 357:1995;362-375.
56. Vos B.P., Strassman A.M., Maciewicz R.J. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci. 14:1994;2708-2723.
57. Woolf C.J., Doubell T.P. The pathophysiology of chronic pain-increased sensitivity to low threshold Ab-fibre inputs. Curr Opin Neurobiol. 4:1994;525-534.
58. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartate acid receptor activation: implication for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
59. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett. 135:1992;67-70.
60. Zenz M., Strumpf M., Tryba M. Long-term oral opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage. 7:1992;69-77.
61. Zhang K.M., Wang X.M., Mokha S.S. Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis). Brain Res. 719:1996;229-233.